Dermatology Foundation award trends - 10/10/20
Funding sources: None. |
|
Disclosure: Dr Shi is a stock shareholder of Learn Health; has served as an advisory board member, investigator, and/or received research funding from Sanofi Genzyme, Regeneron, AbbVie, Eli Lilly, Novartis, Sun Pharma, LEO Pharma, Pfizer, Menlo Therapeutics, Burt's Bees, GpSkin, Altus Labs, and Skin Actives Scientific; and has received a research grant from the Dermatology Foundation; there were no incentives or transactions, financial or otherwise, relevant to this manuscript. Ms Price, Ms Atluri, and Dr Hsiao have no conflicts of interest to declare. |
|
IRB approval status: Not applicable. |
|
Reprints not available from the authors. |
Vol 83 - N° 5
P. 1470-1473 - novembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?